Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009

Vaccine

Volumn 29, Issue 1, 2010, Pages 58-64

  Lindsey, Nicole P ^a   Staples, J Erin ^a   Jones, James F ^b   Sejvar, James J ^a   Griggs, Anne ^a   Iskander, John ^b   Miller, Elaine R ^b   Fischer, Marc ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Adverse event; Japanese encephalitis; Vaccine; VAERS

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE;

ADOLESCENT; ADULT; AGED; ARMY; ARTICLE; ATAXIA; ATHEROSCLEROSIS; BELL PALSY; BRONCHOSPASM; CARDIOMEGALY; CHILD; DEATH; DIZZINESS; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DYSPNEA; FACE SWELLING; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; INFANT; INJECTION SITE ERYTHEMA; INJECTION SITE PARESTHESIA; INJECTION SITE PRURITUS; INJECTION SITE URTICARIA; JAPANESE ENCEPHALITIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SIDE EFFECT; TACHYCARDIA; UNITED STATES; UPPER AIRWAY SWELLING; VACCINATION; WEAKNESS; WHEEZING;

ADOLESCENT; ADULT; ENCEPHALITIS, JAPANESE; FEMALE; HUMANS; HYPERSENSITIVITY; INCIDENCE; JAPANESE ENCEPHALITIS VACCINES; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; UNITED STATES; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 78649703063     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.016     Document Type: Article

References (32)

1. Fischer M., Griggs A., Staples J.E. Japanese encephalitis. Health information for international travel 2010 2009, 74-81. U.S. Department of Health and Human Services, Public Health Service, Atlanta. G. Brunette, P. Kozarsky, A. Magill, D. Shlim, A. Whatley (Eds.).
2. Marfin A.A., Eidex R.S., Kozarsky P.E. Cetron MS. Yellow fever and Japanese encephalitis vaccines: indications and complications. Infect Dis Clin North Am 2005, 19(1):151-168.
3. Shlim D.R., Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis 2002, 35(2):183-188.
4. CDC Japanese encephalitis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010, 59(RR-1):1-27.
5. CDC Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1993, 42(RR-1):1-15.
6. Poland J.D., Cropp C.B., Craven R.B., Monath T.P. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis 1990, 161:878-882.
7. Defraites R.F., Gambel J.M., Hoke C.H., Sanchez J.L., Withers B.G., Karabatsos N., et al. Japanese encephalitis vaccine (inactivated BIKEN) in US soldiers: immunogenicity and safety of vaccine administered in two dosing regimens. Am J Trop Med Hyg 1999, 61:288-293.
8. Ohtaki E., Murakami Y., Komori H., Yamashita Y., Matsuishi T. Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination. Pediatr Neurol 1992, 8(2):137-139.
9. Plesner A.M., Ronne T. Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine 1997, 15(11):1239-1243.
10. Plesner A.M., Arlien-Soborg P., Herning M. Neurological complications to vaccination against Japanese encephalitis. Eur J Neurol 1998, 5(5):479-485.
11. Plesner A.M. Allergic reactions to Japanese encephalitis vaccine. Immunol Allergy Clin North Am 2003, 23(4):665-697.
12. Takahashi H., Pool V., Tsai T.F., Chen R.T. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS working group. Vaccine 2000, 18(26):2963-2969.
13. Andersen M.M., Ronne T. Side-effects with Japanese encephalitis vaccine. Lancet 1991, 337(8748):1044.
14. Berg S.W., Mitchell B.S., Hanson R.K., Olafson R.P., Williams R.P., Tueller J.E., et al. Systemic reactions in US marine corps personnel who received Japanese encephalitis vaccine. Clin Infect Dis 1997, 24(2):265-266.
15. Bonington A., Harbord M., Davidson R.N., Cropley I., Behrens R.H. Immunisation against Japanese encephalitis. Lancet 1995, 345(8962):1445-1446.
16. Nazareth B., Levin J., Johnson H., Begg N. Systemic allergic reactions to Japanese encephalitis vaccines. Vaccine 1994, 12(7):666.
17. Ruff T.A., Eisen D., Fuller A., Kass R. Adverse reactions to Japanese encephalitis vaccine. Lancet 1991, 338(8771):881-882.
18. Iskander J.K., Miller E.R., Chen R.T. The role of the Vaccine Adverse Event Reporting System (VAERS) in monitoring vaccine safety. Pediatr Ann 2004, 33(9):599-606.
19. Varricchio F., Iskander J., Destefano F., Ball R., Pless R., Braun M.M., et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004, 23(4):287-294.
20. Brown E.G., Wood L., Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf 1999, 20(2):109-117.
21. 21CFR600.80 (Code of Federal Regulations, Title 21, Part 600, Sec. 600.80). Postmarketing reporting of adverse experiences. Available at http://edocket.access.gpo.gov/cfr_2010/aprqtr/pdf/21cfr600.80.pdf.
22. Ruggeberg J.U., Gold M.S., Bayas J.M., Blum M.D., Bonhoeffer J., Friedlander S., et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25(31):5675-5684.
23. Sejvar J.J., Kohl K.S., Gidudu J., Amato A., Bakshi N., Baxter R., et al. Guillain-Barré Syndrome and Fisher Syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2010, (June). [epub ahead of print].
24. Sejvar J.J., Kohl K.S., Bilynsky R., Blumberg D., Cvetkovich T., Galama J., et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25(31):5771-5792.
25. Tapiainen T., Prevots R., Izurieta H.S., Abramson J., Bilynsky R., Bonhoeffer J., et al. Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine 2007, 25(31):5793-5802.
26. Torres M.J., Mayorga C., Blanca M. Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests. J Investig Allergol Clin Immunol 2009, 19(2):80-90.
27. Schnyder B. Approach to the patient with drug allergy. Immunol Allergy Clin N Am 2009, 29:405-418.
28. Zhou W., Pool V., Iskander J.K., English-Bullard R., Ball R., Wise R.P., et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. MMWR Surveill Summ 2003, 52(1):1-24.
29. Franklin Q.J. Sudden death after typhoid and Japanese encephalitis vaccination in a young male taking pseudoephedrine. Military Med 1999, 184:157-159.
30. Iskander J.K., Chen R.T. Public health surveillance for vaccine adverse events. Infectious disease surveillance 2007, 241-253. Blackwell Publishing, Malden. N.M. M'ikanatha, R. Lynfield, C.A. Van Beneden, H. de Valk (Eds.).
31. Dobardzic A., Izurieta H., Woo E.J., Iskander J., Shadomy S., Rupprecht C., et al. Safety review of the purified chick embryo cell rabies vaccine: data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005. Vaccine 2007, 25(21):4244-4251.
32. Begier E.M., Burwen D.R., Haber P., Ball R Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002. Clin Infect Dis 2004, 38(6):771-779. Vaccine Adverse Event Reporting System working group.